Share Price and Basic Stock Data
Last Updated: February 22, 2025, 12:02 am
PEG Ratio | 3.81 |
---|
Competitors of AKG Exim Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
MRC Agrotech Ltd | 22.8 Cr. | 11.1 | 20.5/10.2 | 15.2 | 0.00 % | % | % | 10.0 | |
MRP Agro Ltd | 152 Cr. | 137 | 174/45.2 | 31.0 | 14.6 | 0.00 % | 12.3 % | 9.53 % | 10.0 |
Muller and Phipps (India) Ltd | 22.0 Cr. | 352 | 726/190 | 23.8 | 0.00 % | % | % | 10.0 | |
Mystic Electronics Ltd | 9.19 Cr. | 4.65 | 8.88/3.30 | 29.6 | 14.3 | 0.00 % | 1.09 % | 1.06 % | 10.0 |
Ind-Agiv Commerce Ltd | 10.4 Cr. | 104 | 190/50.0 | 57.7 | 0.00 % | 17.9 % | % | 10.0 | |
Industry Average | 9,618.64 Cr | 152.28 | 103.14 | 121.71 | 0.22% | 12.76% | 9.58% | 7.88 |
Quarterly Result
Metric | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 23.02 | 35.20 | 54.19 | 75.19 | 46.31 | 48.46 | 67.90 | 58.20 | 56.09 | 36.59 | 44.76 | 46.30 | 40.38 |
Expenses | 22.91 | 34.36 | 53.34 | 74.21 | 45.65 | 48.67 | 67.42 | 56.92 | 55.29 | 35.99 | 43.93 | 45.98 | 39.78 |
Operating Profit | 0.11 | 0.84 | 0.85 | 0.98 | 0.66 | -0.21 | 0.48 | 1.28 | 0.80 | 0.60 | 0.83 | 0.32 | 0.60 |
OPM % | 0.48% | 2.39% | 1.57% | 1.30% | 1.43% | -0.43% | 0.71% | 2.20% | 1.43% | 1.64% | 1.85% | 0.69% | 1.49% |
Other Income | 0.42 | 0.06 | 0.00 | 0.11 | 0.02 | 1.03 | 0.60 | 0.36 | 0.15 | 0.12 | 0.11 | 0.50 | 0.03 |
Interest | 0.20 | 0.24 | 0.18 | 0.20 | 0.21 | 0.23 | 0.33 | 0.30 | 0.34 | 0.31 | 0.31 | 0.29 | 0.29 |
Depreciation | 0.03 | 0.04 | 0.04 | 0.05 | 0.02 | 0.02 | 0.02 | 0.12 | 0.03 | 0.03 | 0.05 | 0.09 | 0.04 |
Profit before tax | 0.30 | 0.62 | 0.63 | 0.84 | 0.45 | 0.57 | 0.73 | 1.22 | 0.58 | 0.38 | 0.58 | 0.44 | 0.30 |
Tax % | 13.33% | 25.81% | 25.40% | 20.24% | 15.56% | 26.32% | 26.03% | 21.31% | 20.69% | 26.32% | 20.69% | 38.64% | 26.67% |
Net Profit | 0.25 | 0.46 | 0.47 | 0.66 | 0.39 | 0.42 | 0.54 | 0.97 | 0.46 | 0.28 | 0.47 | 0.27 | 0.22 |
EPS in Rs | 0.08 | 0.14 | 0.16 | 0.21 | 0.13 | 0.14 | 0.18 | 0.31 | 0.16 | 0.10 | 0.15 | 0.09 | 0.08 |
Last Updated: Unknown
Profit & Loss - Annual Report
Last Updated: Unknown
Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|
Sales | 118 | 66 | 104 | 186 | 221 | 196 |
Expenses | 115 | 66 | 102 | 183 | 218 | 192 |
Operating Profit | 3 | 0 | 3 | 3 | 3 | 4 |
OPM % | 3% | 1% | 3% | 2% | 1% | 2% |
Other Income | 1 | 3 | 0 | 0 | 1 | 1 |
Interest | 2 | 2 | 1 | 1 | 1 | 1 |
Depreciation | 0 | 1 | 0 | 0 | 0 | 0 |
Profit before tax | 2 | 2 | 2 | 2 | 3 | 3 |
Tax % | 28% | 28% | 23% | 20% | 17% | |
Net Profit | 1 | 1 | 1 | 2 | 2 | 2 |
EPS in Rs | 0.34 | 0.34 | 0.43 | 0.61 | 0.78 | 0.72 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
Year | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 |
---|---|---|---|---|
YoY Net Profit Growth (%) | 0.00% | 0.00% | 100.00% | 0.00% |
Change in YoY Net Profit Growth (%) | 0.00% | 0.00% | 100.00% | -100.00% |
AKG Exim Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2019-2020 to 2022-2023.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 9% |
3 Years: | 21% |
TTM: | -23% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 7% |
3 Years: | 4% |
TTM: | -64% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 12% |
3 Years: | -6% |
1 Year: | -33% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 5% |
Last Year: | 3% |
Last Updated: Unknown
Balance Sheet
Last Updated: January 13, 2025, 4:08 pm
Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|
Equity Capital | 7 | 11 | 11 | 32 | 32 | 32 |
Reserves | 13 | 10 | 13 | 19 | 21 | 21 |
Borrowings | 10 | 10 | 13 | 12 | 14 | 14 |
Other Liabilities | 2 | 4 | 9 | 9 | 12 | -8 |
Total Liabilities | 31 | 36 | 45 | 73 | 79 | 59 |
Fixed Assets | 1 | 1 | 1 | 1 | 2 | 2 |
CWIP | 0 | 1 | 2 | 2 | 2 | 2 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Other Assets | 31 | 34 | 43 | 70 | 75 | 55 |
Total Assets | 31 | 36 | 45 | 73 | 79 | 59 |
Cash Flow
Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|
Free Cash Flow | 3.00 | -10.00 | -7.00 | -10.00 | -9.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|
Debtor Days | 95 | 82 | 63 | 73 | 68 | |
Inventory Days | 19 | 12 | 7 | 20 | 17 | |
Days Payable | 6 | 11 | 13 | 14 | 17 | |
Cash Conversion Cycle | 108 | 82 | 57 | 79 | 68 | |
Working Capital Days | 140 | 103 | 62 | 83 | 118 | |
ROCE % | 9% | 11% | 9% | 5% |
This stock is not held by any mutual fund
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 0.48 | 0.78 | 1.93 | 1.01 | 1.64 |
Diluted EPS (Rs.) | 0.48 | 0.78 | 1.93 | 1.01 | 1.64 |
Cash EPS (Rs.) | 0.54 | 0.83 | 1.98 | 1.48 | 2.51 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 16.55 | 16.06 | 21.83 | 20.04 | 29.74 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 16.55 | 16.06 | 21.83 | 20.04 | 29.74 |
Revenue From Operations / Share (Rs.) | 57.78 | 69.59 | 175.92 | 98.55 | 100.27 |
PBDIT / Share (Rs.) | 1.08 | 1.33 | 3.22 | 2.68 | 5.14 |
PBIT / Share (Rs.) | 1.01 | 1.27 | 3.07 | 2.51 | 4.27 |
PBT / Share (Rs.) | 0.62 | 0.93 | 2.28 | 1.67 | 2.29 |
Net Profit / Share (Rs.) | 0.48 | 0.77 | 1.83 | 1.31 | 1.64 |
NP After MI And SOA / Share (Rs.) | 0.48 | 0.77 | 1.83 | 1.31 | 1.64 |
PBDIT Margin (%) | 1.86 | 1.91 | 1.83 | 2.71 | 5.12 |
PBIT Margin (%) | 1.75 | 1.83 | 1.74 | 2.55 | 4.26 |
PBT Margin (%) | 1.07 | 1.35 | 1.29 | 1.69 | 2.28 |
Net Profit Margin (%) | 0.83 | 1.12 | 1.04 | 1.32 | 1.63 |
NP After MI And SOA Margin (%) | 0.83 | 1.12 | 1.04 | 1.32 | 1.63 |
Return on Networth / Equity (%) | 2.91 | 4.85 | 8.39 | 6.57 | 5.51 |
Return on Capital Employeed (%) | 6.02 | 7.84 | 13.80 | 12.18 | 13.84 |
Return On Assets (%) | 1.94 | 3.41 | 4.30 | 3.89 | 3.45 |
Long Term Debt / Equity (X) | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
Total Debt / Equity (X) | 0.26 | 0.24 | 0.54 | 0.47 | 0.50 |
Asset Turnover Ratio (%) | 2.42 | 3.76 | 3.27 | 2.35 | 0.00 |
Current Ratio (X) | 2.92 | 3.31 | 1.99 | 2.44 | 2.75 |
Quick Ratio (X) | 2.62 | 2.76 | 1.84 | 2.21 | 2.48 |
Interest Coverage Ratio (X) | 2.75 | 3.97 | 4.07 | 3.18 | 2.59 |
Interest Coverage Ratio (Post Tax) (X) | 2.23 | 3.33 | 3.31 | 2.55 | 1.83 |
Enterprise Value (Cr.) | 67.94 | 102.02 | 50.21 | 80.52 | 28.43 |
EV / Net Operating Revenue (X) | 0.37 | 0.46 | 0.26 | 0.77 | 0.42 |
EV / EBITDA (X) | 19.80 | 24.13 | 14.71 | 28.38 | 8.35 |
MarketCap / Net Operating Revenue (X) | 0.30 | 0.45 | 0.21 | 0.67 | 0.32 |
Price / BV (X) | 1.08 | 1.96 | 1.72 | 3.34 | 1.11 |
Price / Net Operating Revenue (X) | 0.30 | 0.45 | 0.21 | 0.67 | 0.32 |
EarningsYield | 0.02 | 0.02 | 0.04 | 0.01 | 0.04 |
After reviewing the key financial ratios for AKG Exim Ltd, here is a detailed analysis based on recent trends:
For FaceValue, the latest value as of Mar 20 is 10 which is within the healthy range. Compared to Mar 21, there was no change.
For Basic EPS (Rs.), the latest value as of Mar 20 is 1.64 which is below the healthy minimum of 5. Compared to Mar 21, there was an increase of 0.63.
For Diluted EPS (Rs.), the latest value as of Mar 20 is 1.64 which is below the healthy minimum of 5. Compared to Mar 21, there was an increase of 0.63.
For Cash EPS (Rs.), the latest value as of Mar 20 is 2.51 which is below the healthy minimum of 3. Compared to Mar 21, there was an increase of 1.03.
For Book Value[Excl.RevalReserv]/Share (Rs.), the latest value as of Mar 20 is 29.74 Compared to Mar 21, there was an increase of 9.7.
For Book Value[Incl.RevalReserv]/Share (Rs.), the latest value as of Mar 20 is 29.74 Compared to Mar 21, there was an increase of 9.7.
For Revenue From Operations / Share (Rs.), the latest value as of Mar 20 is 100.27 Compared to Mar 21, there was an increase of 1.72.
For PBDIT / Share (Rs.), the latest value as of Mar 20 is 5.14 which is within the healthy range. Compared to Mar 21, there was an increase of 2.46.
For PBIT / Share (Rs.), the latest value as of Mar 20 is 4.27 which is within the healthy range. Compared to Mar 21, there was an increase of 1.76.
For PBT / Share (Rs.), the latest value as of Mar 20 is 2.29 which is within the healthy range. Compared to Mar 21, there was an increase of 0.62.
For Net Profit / Share (Rs.), the latest value as of Mar 20 is 1.64 which is below the healthy minimum of 2. Compared to Mar 21, there was an increase of 0.33.
For NP After MI And SOA / Share (Rs.), the latest value as of Mar 20 is 1.64 which is below the healthy minimum of 2. Compared to Mar 21, there was an increase of 0.33.
For PBDIT Margin (%), the latest value as of Mar 20 is 5.12 which is below the healthy minimum of 10. Compared to Mar 21, there was an increase of 2.41.
For PBIT Margin (%), the latest value as of Mar 20 is 4.26 which is below the healthy minimum of 10. Compared to Mar 21, there was an increase of 1.71.
For PBT Margin (%), the latest value as of Mar 20 is 2.28 which is below the healthy minimum of 10. Compared to Mar 21, there was an increase of 0.59.
For Net Profit Margin (%), the latest value as of Mar 20 is 1.63 which is below the healthy minimum of 5. Compared to Mar 21, there was an increase of 0.31.
For NP After MI And SOA Margin (%), the latest value as of Mar 20 is 1.63 which is below the healthy minimum of 8. Compared to Mar 21, there was an increase of 0.31.
For Return on Networth / Equity (%), the latest value as of Mar 20 is 5.51 which is below the healthy minimum of 15. Compared to Mar 21, there was a decrease of 1.06.
For Return on Capital Employeed (%), the latest value as of Mar 20 is 13.84 which is within the healthy range. Compared to Mar 21, there was an increase of 1.66.
For Return On Assets (%), the latest value as of Mar 20 is 3.45 which is below the healthy minimum of 5. Compared to Mar 21, there was a decrease of 0.44.
For Long Term Debt / Equity (X), the latest value as of Mar 20 is 0.02 which is below the healthy minimum of 0.2. Compared to Mar 21, there was an increase of 0.01.
For Total Debt / Equity (X), the latest value as of Mar 20 is 0.5 which is within the healthy range. Compared to Mar 21, there was an increase of 0.03.
For Asset Turnover Ratio (%), the latest value as of Mar 20 is 0 Compared to Mar 21, there was a decrease of 2.35.
For Current Ratio (X), the latest value as of Mar 20 is 2.75 which is within the healthy range. Compared to Mar 21, there was an increase of 0.31.
For Quick Ratio (X), the latest value as of Mar 20 is 2.48 which exceeds the healthy maximum of 2. Compared to Mar 21, there was an increase of 0.27.
For Interest Coverage Ratio (X), the latest value as of Mar 20 is 2.59 which is below the healthy minimum of 3. Compared to Mar 21, there was a decrease of 0.59.
For Interest Coverage Ratio (Post Tax) (X), the latest value as of Mar 20 is 1.83 which is below the healthy minimum of 3. Compared to Mar 21, there was a decrease of 0.72.
For Enterprise Value (Cr.), the latest value as of Mar 20 is 28.43 Compared to Mar 21, there was a decrease of 52.09.
For EV / Net Operating Revenue (X), the latest value as of Mar 20 is 0.42 which is below the healthy minimum of 1. Compared to Mar 21, there was a decrease of 0.35.
For EV / EBITDA (X), the latest value as of Mar 20 is 8.35 which is within the healthy range. Compared to Mar 21, there was a decrease of 20.03.
For MarketCap / Net Operating Revenue (X), the latest value as of Mar 20 is 0.32 which is below the healthy minimum of 1. Compared to Mar 21, there was a decrease of 0.35.
For Price / BV (X), the latest value as of Mar 20 is 1.11 which is within the healthy range. Compared to Mar 21, there was a decrease of 2.23.
For Price / Net Operating Revenue (X), the latest value as of Mar 20 is 0.32 which is below the healthy minimum of 1. Compared to Mar 21, there was a decrease of 0.35.
For EarningsYield, the latest value as of Mar 20 is 0.04 which is below the healthy minimum of 5. Compared to Mar 21, there was an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation. If you have any questions or need more detailed insights, please feel free to reach out.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in AKG Exim Ltd:
- Net Profit Margin: 0.83%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 6.02% (Industry Average ROCE: 12.76%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 2.91% (Industry Average ROE: 9.58%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.23
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.62
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 61.7 (Industry average Stock P/E: 103.14)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.26
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.83%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Trading & Distributors | H.B. Twin Tower, 07 Floor, Max Hospital Building, Delhi Delhi 110034 | info@akg-global.com http://www.akg-global.com |
Management | |
---|---|
Name | Position Held |
Mrs. Mahima Goel | Managing Director |
Mr. Rahul Bajaj | Executive Director & CFO |
Mr. Rajeev Goel | Non Executive Director |
Mr. Rao Laxman Singh | Independent Director |
Mr. Rakesh Mohan | Independent Director |
Ms. Chetna | Independent Director |
FAQ
What is the latest intrinsic value of AKG Exim Ltd?
Let's break down AKG Exim Ltd's intrinsic value simply:
We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.
As of 24 February 2025:
- Calculated Fair Value: ₹24.82
- Current Market Price: ₹15.30
- Variance: 62.22% higher
This suggests AKG Exim Ltd is currently undervalued by 62.22%. For context:
- Market Cap: 48.7 Cr.
- 52-Week Range: 25.7/14.0
- Reserves (Sep 2024): ₹21 Cr
- Liabilities: 59 Cr
Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.
What is the Market Cap of AKG Exim Ltd?
The Market Cap of AKG Exim Ltd is 48.7 Cr..
What is the current Stock Price of AKG Exim Ltd as on 24 February 2025?
The current stock price of AKG Exim Ltd as on 24 February 2025 is ₹15.3.
What is the High / Low of AKG Exim Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of AKG Exim Ltd stocks is 25.7/14.0.
What is the Stock P/E of AKG Exim Ltd?
The Stock P/E of AKG Exim Ltd is 61.7.
What is the Book Value of AKG Exim Ltd?
The Book Value of AKG Exim Ltd is 16.6.
What is the Dividend Yield of AKG Exim Ltd?
The Dividend Yield of AKG Exim Ltd is 0.00 %.
What is the ROCE of AKG Exim Ltd?
The ROCE of AKG Exim Ltd is 5.29 %.
What is the ROE of AKG Exim Ltd?
The ROE of AKG Exim Ltd is 2.97 %.
What is the Face Value of AKG Exim Ltd?
The Face Value of AKG Exim Ltd is 10.0.